Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Clinical experience with insulin glargine in type 1 diabetes.

Garg S, Moser E, Dain MP, Rodionova A.

Diabetes Technol Ther. 2010 Nov;12(11):835-46. doi: 10.1089/dia.2010.0135. Epub 2010 Oct 22. Review.

PMID:
20969435
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
[PubMed - indexed for MEDLINE]
4.

A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.

Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA.

Pediatrics. 2008 Mar;121(3):e466-72. doi: 10.1542/peds.2007-1679. Epub 2008 Feb 25.

PMID:
18299307
[PubMed - indexed for MEDLINE]
Free Article
5.

Insulin glargine.

Campbell RK, White JR, Levien T, Baker D.

Clin Ther. 2001 Dec;23(12):1938-57; discussion 1923. Review.

PMID:
11813930
[PubMed - indexed for MEDLINE]
6.

Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.

Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.

Clin Ther. 2006 Dec;28(12):2094-101.

PMID:
17296465
[PubMed - indexed for MEDLINE]
7.

Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.

McKeage K, Goa KL.

Treat Endocrinol. 2002;1(1):55-8. Review.

PMID:
15765621
[PubMed - indexed for MEDLINE]
8.

Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.

McKeage K, Goa KL.

Drugs. 2001;61(11):1599-624. Review.

PMID:
11577797
[PubMed - indexed for MEDLINE]
9.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

PMID:
15525480
[PubMed - indexed for MEDLINE]
Free Article
10.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

PMID:
20646668
[PubMed - indexed for MEDLINE]
Free Article
11.

Insulin glargine in the treatment of type 1 and type 2 diabetes.

Barnett AH.

Vasc Health Risk Manag. 2006;2(1):59-67. Review.

PMID:
17319470
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
[PubMed - indexed for MEDLINE]
13.

Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.

Duckworth W, Davis SN.

J Diabetes Complications. 2007 May-Jun;21(3):196-204. Review.

PMID:
17493554
[PubMed - indexed for MEDLINE]
14.

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. Review.

PMID:
17443605
[PubMed - indexed for MEDLINE]
15.

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.

Raslova K.

Vasc Health Risk Manag. 2010 Jun 1;6:399-410. Review.

PMID:
20539842
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus.

Miles HL, Acerini CL.

Paediatr Drugs. 2008;10(3):163-76. Review.

PMID:
18454569
[PubMed - indexed for MEDLINE]
17.

Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.

Chatterjee S, Tringham JR, Davies MJ.

Expert Opin Pharmacother. 2006 Jul;7(10):1357-71. Review.

PMID:
16805721
[PubMed - indexed for MEDLINE]
18.

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.

Peterson GE.

Curr Med Res Opin. 2006 Dec;22(12):2613-9. Review.

PMID:
17166343
[PubMed - indexed for MEDLINE]
19.

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.

Fulcher GR, Gilbert RE, Yue DK.

Intern Med J. 2005 Sep;35(9):536-42.

PMID:
16105155
[PubMed - indexed for MEDLINE]
20.

Spotlight on insulin detemir in type 1 and 2 diabetes mellitus.

Chapman TM, Perry CM.

BioDrugs. 2005;19(1):67-9.

PMID:
15691219
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk